Advertisement

Informed Consent and the Ethics of Placebo-Based Interventions in Clinical Practice

  • Marco AnnoniEmail author
  • Franklin G. Miller
Chapter
Part of the Headache book series (HEAD)

Abstract

In this chapter we explore the ethics of informed consent with respect to the prescription of effective treatments, like acupuncture, that according to evidence-based standards have a prevalent placebo component. First, we review empirical studies demonstrating that placebo effects may significantly modulate symptoms in highly prevalent conditions, taking migraine as our case in point. Next, we chart the ethical implications of prescribing interventions that have been found slightly more effective than placebos and yet significantly better than no treatment—a class of remedies that we label as “placebo-based interventions.” We argue that, provided certain conditions are met, doctors may ethically prescribe placebo-based interventions in nondeceptive ways. By contrast, we contend the prescription of placebo treatments is incompatible with informed consent unless the true nature of the remedy is transparently disclosed to patients.

Keywords

Placebo effects Migraine Acupuncture Informed consent Doctor-patient communication 

References

  1. 1.
    Annoni M, Miller FG. Placebo in clinical practice: an ethical overview. Douleur Analg. 2014;27:215–20.CrossRefGoogle Scholar
  2. 2.
    Annoni M. Exceptional lies: the ethics of deceptive placebos in clinical settings. Biblioteca della libertà. 2015;213:1–17.Google Scholar
  3. 3.
    Annoni M, Miller FG. Placebo effects and the ethics of therapeutic communication: a pragmatic perspective. Kennedy Inst Ethics J. 2016;26:79–103.CrossRefGoogle Scholar
  4. 4.
    Beauchamp TL, Childress JF. Principles of biomedical ethics. New York and Oxford: Oxford University Press; 2009.Google Scholar
  5. 5.
    Benedetti F. Placebo effects: understanding the mechanisms in health and disease. 2nd ed. New York: Oxford University Press; 2015.Google Scholar
  6. 6.
    Blease C, Colloca L, Kaptchuk TJ. Are open-label placebos ethical? Informed consent and ethical considerations. Bioethics. 2016;30:407–14.CrossRefGoogle Scholar
  7. 7.
    Blease CR, Bishop FL, Kaptchuk TJ. Informed consent and clinical trials: where is the placebo effect? BMJ. 2017;356:j463.CrossRefGoogle Scholar
  8. 8.
    Chaibi A, Benth JS, Russell MB. Validation of placebo in a manual therapy randomized controlled trial. Sci Rep. 2015;5:11774.CrossRefGoogle Scholar
  9. 9.
    Chaibi A, Benth JS, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur J Neurol. 2017;24:143–53.CrossRefGoogle Scholar
  10. 10.
    Colloca L. Tell me the truth and I will not be harmed: informed consents and nocebo effects. Am J Bioeth. 2017;17:46–8.CrossRefGoogle Scholar
  11. 11.
    Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307:567–8.CrossRefGoogle Scholar
  12. 12.
    Fortunato J, Wasserman J, Menkes DL. When respecting autonomy is harmful: a clinically useful approach to the nocebo effect. Am J Bioeth. 2017;17:36–42.CrossRefGoogle Scholar
  13. 13.
    Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher J, Jensen KB, Conboy LA, Kelley JM, Kokkotou E, Kaptchuk TJ. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012;7:e48135.CrossRefGoogle Scholar
  14. 14.
    Justman S. Deceit and transparency in placebo research. Yale J Biol Med. 2013;86:323–31.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014;6:218ra215.CrossRefGoogle Scholar
  16. 16.
    Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008;336:999.CrossRefGoogle Scholar
  17. 17.
    Kaptchuk TJ, Miller FG. Placebo effects in medicine. N Engl J Med. 2015;373:8–9.CrossRefGoogle Scholar
  18. 18.
    Kolber AJ. A limited defense of clinical placebo deception. Yale Policy Rev. 2007;26:75–134.Google Scholar
  19. 19.
    Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, Vickers A, White AR. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;6:CD001218.Google Scholar
  20. 20.
    Lionetto L, Negro A, Palmisani S, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012;17:393–406.CrossRefGoogle Scholar
  21. 21.
    Martelletti P. The therapeutic armamentarium in migraine is quite elderly. Expert Opin Drug Metab Toxicol. 2015;11:175–7.CrossRefGoogle Scholar
  22. 22.
    Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9:39–47.CrossRefGoogle Scholar
  23. 23.
    Miller FG, Colloca L, Kaptchuk TJ. The placebo effect: illness and interpersonal healing. Perspect Biol Med. 2009;52:518–39.CrossRefGoogle Scholar
  24. 24.
    Miller FG, Brody H. Understanding and harnessing placebo effects: clearing away the underbrush. J Med Philos. 2011;36:69–78.CrossRefGoogle Scholar
  25. 25.
    Miller FG, Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor Med Bioeth. 2011;32:229–43.CrossRefGoogle Scholar
  26. 26.
    Miller FG. The concept and significance of the placebo effect. In: Miller FG, Colloca L, Crouch R, Kaptchuk TJ, editors. The placebo: a reader. Baltimore: The Johns Hopkins University Press; 2013. p. 1–9.Google Scholar
  27. 27.
    Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain. 2011;12:593–601.CrossRefGoogle Scholar
  28. 28.
    Petkovic G, Charlesworth JEG, Kelley J, et al. Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis. BMJ Open. 2015;5:e009428.CrossRefGoogle Scholar
  29. 29.
    Wager TD, Atlas L. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16:403–17.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Consiglio Nazionale delle RicercheIstituto di Tecnologie BiomedicheRomeItaly
  2. 2.Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations